C20H14ClF3N4O3
Neat
450.81
+5°C
Room Temperature
N-Desmethyl sorafenib; 284461-74-1; Sorafenib Impurity 18; Sorafenib metabolite M4; 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]pyridine-2-carboxamide; BAY-439007; CHEMBL403732; N4T1W2J64C; 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)picolinamide; 2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-; BAY 43-9007; BAY-43-9007; 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)picolinamide?; n-(4-chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-carbamoyl-4-pyridyloxy)phenyl)urea; 2-Pyridinecarboxamide and 4-(4-((((4-chloro-3-(trifluoromethyl) phenyl)amino)carbonyl)amino)phenoxy)-; UNII-N4T1W2J64C; C20H14ClF3N4O3; SCHEMBL548133; SCHEMBL29918250; DTXSID101117356
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]pyridine-2-carboxamide
InChI=1S/C20H14ClF3N4O3/c21-16-6-3-12(9-15(16)20(22,23)24)28-19(30)27-11-1-4-13(5-2-11)31-14-7-8-26-17(10-14)18(25)29/h1-10H,(H2,25,29)(H2,27,28,30)